We often associate some cancer types with being more aggressive than others. Patients receiving a glioblastoma (an aggressive brain cancer) or colon cancer diagnosis live in fear of fast-approaching complications. On the other hand, some cancers, like many prostate cancers, often grow slowly (though others can be aggressive), making them easier to treat and rarely fatal.
However, why exactly some cancers behave as they do remains a mystery to scientists. To better understand why some cancers are worse than others across the spectrum of different cancer types, researchers from Virginia Tech took a closer look at chromosome numbers and the sizes of cancer cells.
Publishing their findings in Cancer Biology and the Proceedings of the National Academy of Sciences, the team describes how smaller cancer cells, despite carrying an unusual number of chromosomes, are more aggressive and resistant to cancer drugs than other cells. To their surprise, this pattern recurred across cancer databases, regardless of cancer type.
When Chromosome Counts Go Awry
When we compare normal, healthy cells to cancer cells, a different number of chromosomes often stands out. Since our DNA, if laid out straight, wouldn’t fit inside our cells, the strands carrying all our genetic information are densely coiled and packed into 23 pairs of chromosomes. Most cells are diploid, meaning they have a double set of chromosomes in each nucleus, the control center of every cell.
When cells divide, they duplicate their chromosomes, temporarily holding four sets within a single cell. Sometimes, the division process gets stuck, producing a cell with an abnormal chromosome count, a common way cancer cells can form.
Focusing on the impact of chromosomal abnormalities on cancer progression, the research team artificially created cancer cells with four sets of chromosomes, called tetraploid cells. This characteristic, if observed in real tumor samples, is considered a sign of aggressiveness and is often associated with poor patient prognosis.
Read more: Disrupting DNA Repair May Help Defeat Drug-Resistant Cancer
Surprisingly, Small Cancer Cells Are More Aggressive
Despite the common knowledge that tetraploid cancer cells drive tumor growth, the exact process behind it, and therefore the potential mechanisms that could be targeted for treatment, isn’t clearly understood. In their study, the researchers observed for the first time that tumor growth driven by tetraploid cells heavily relied on a specific helper.
To build a sturdy tumor, the cancer cells recruited non-cancerous connective tissue cells called stromal cells.
“The presence of even a small fraction of these tetraploid cells can promote the recruitment of extra non-cancerous cells that support further tumor progression,” explained study co-author Megan Sweet in a press statement.
Another unexpected finding was how much size mattered. Not all tetraploid cancer cells in their experiments had the same volume, even though they contained the same number of extra chromosomes, which would be expected to require more space. Some cancer cells were 25 to 30 percent smaller and displayed more aggressive behavior than larger ones.
“The smaller clones are more aggressive,” said lead author Mat Bloomfield in the release. “They grow faster, are more invasive, and more tolerant of common anti-cancer and stress-inducing drugs.”
Cancer Type Is Not Always the Sole Indicator of Tumor Aggressiveness
Follow-up experiments in mice supported the findings. Tumors with smaller tetraploid cells were more likely to grow faster, regardless of the cancer type. If the tetraploid characteristic was present, it didn’t matter whether the cancer was colorectal or breast cancer. The researchers further confirmed their findings using matching data from The Cancer Genome Atlas, which contains thousands of patient samples.
“We already knew that tetraploidy can make cells more tumorigenic,” said corresponding author Daniela Cimini, professor at Virginia Tech’s Department of Biological Sciences, in the statement. “But now we know that if you incorporate the size of the cells, it can be more predictive of tumorigenic potential.”
This discovery opens the door to further understanding the underlying mechanisms and analyzing more human cancer data to identify possible treatment avenues that could alter cancer cell size.
This article is not offering medical advice and should be used for informational purposes only.
Read more: 70-Year-Old Tumor Samples May Help Shed Light on the Rise of Colorectal Cancer in Younger Patients
Article Sources
Our writers at Discovermagazine.com use peer-reviewed studies and high-quality sources for our articles, and our editors review for scientific accuracy and editorial standards. Review the sources used below for this article:
- This article references information from a study published in Cancer Biology: Cell and Nuclear Size Is Associated with Chromosomal Instability and Tumorigenicity in Cancer Cells That Undergo Whole Genome Doubling
- This article references information from a study published in PNAS: Oxidative stress and serum deprivation influence the evolution of newly formed tetraploid cells during tumorigenesis













